News Mesoblast lifts off as FDA agrees to review GvHD drug again Regulator has started a priority review of the cell therapy, with a decision due by 2nd August.
News Sought-after obesity drug Wegovy backed for NHS use Use is restricted to two years in patients enrolled in NHS weight management services.
News FDA removes leash from Verzenio in early breast cancer Drug can now be used as adjuvant therapy without Ki-67 testing, taking a brake off prescribing.
News An aura of adult migraine hope as NICE recommends Vyepti Lundbeck’s eptinezumab receives NICE recommendation for the prevention of migraine in adults.
News Dismay as UK raises clawback rate on NHS drug spending Rise in rate to 27.5% from 1st April will damage the UK economy, claim senior industry figures.
News Leqembi still too pricey, says ICER in updated review Side effects create 'uncertainties' as to whether lecanemab's benefits exceed its risks.
News NICE backs first disease-modifying drug for ARG1 deficiency Immedica's Loargys is poised to become the first NHS therapy for ultra-rare genetic disorder ARG1 deficiency that can alter the course of the disease.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
